Lysophospholipid mediators in the vasculature

Paul Mueller; Shaojing Ye; Andrew Morris; Susan S. Smyth

doi:10.1016/j.yexcr.2015.03.016

Lysophospholipid mediators in the vasculature

Paul Mueller, Shaojing Ye, Andrew Morris, Susan S. Smyth

Internal Medicine

Producción científica: Review article › revisión exhaustiva

20 Citas (Scopus)

Idioma original	English
Páginas (desde-hasta)	190-194
Número de páginas	5
Publicación	Experimental Cell Research
Volumen	333
N.º	2
DOI	https://doi.org/10.1016/j.yexcr.2015.03.016
Estado	Published - may 1 2015

Nota bibliográfica

Funding Information:
This work was supported in part by the National Heart Lung and Blood Institute ( R01HL078663 ); the National Institute of General Medical Sciences ( P20GM103527 ); the National Center for Research Resources ( P20RR021954 ); and the National Center for Advancing Translational Sciences ( UL1TR000117 ) of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This material is the result of work supported in part with resources and the use of facilities at the Lexington VA Medical Center. PM was supported in part by a grant from the National Heart Lung and Blood Institute ( T32HL072743 ) and National Center for Advancing Translational Sciences ( TL1TR000115 ). SY was supported in part by a grant from the National Heart Lung and Blood Institute ( T32HL091812 )

Financiación

This work was supported in part by the National Heart Lung and Blood Institute ( R01HL078663 ); the National Institute of General Medical Sciences ( P20GM103527 ); the National Center for Research Resources ( P20RR021954 ); and the National Center for Advancing Translational Sciences ( UL1TR000117 ) of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This material is the result of work supported in part with resources and the use of facilities at the Lexington VA Medical Center. PM was supported in part by a grant from the National Heart Lung and Blood Institute ( T32HL072743 ) and National Center for Advancing Translational Sciences ( TL1TR000115 ). SY was supported in part by a grant from the National Heart Lung and Blood Institute ( T32HL091812 )

Financiadores	Número del financiador
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)	T32HL091812, R01HL120507, T32HL072743, R01HL078663
National Institute of General Medical Sciences	P20GM103527
National Center for Research Resources	P20RR021954, S10RR024598
National Center for Advancing Translational Sciences (NCATS)	UL1TR000117, TL1TR000115

ASJC Scopus subject areas

Cell Biology

Acceder al documento

10.1016/j.yexcr.2015.03.016

Otros archivos y enlaces

Citar esto

@article{520086f09772482185f1dcd026553b8a,

title = "Lysophospholipid mediators in the vasculature",

keywords = "Atherosclerosis, Autotaxin, Endothelial cells, Lipid phosphate phosphatase, Lysophosphatidic acid, Smooth muscle cells",

author = "Paul Mueller and Shaojing Ye and Andrew Morris and Smyth, \{Susan S.\}",

note = "Funding Information: This work was supported in part by the National Heart Lung and Blood Institute ( R01HL078663 ); the National Institute of General Medical Sciences ( P20GM103527 ); the National Center for Research Resources ( P20RR021954 ); and the National Center for Advancing Translational Sciences ( UL1TR000117 ) of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This material is the result of work supported in part with resources and the use of facilities at the Lexington VA Medical Center. PM was supported in part by a grant from the National Heart Lung and Blood Institute ( T32HL072743 ) and National Center for Advancing Translational Sciences ( TL1TR000115 ). SY was supported in part by a grant from the National Heart Lung and Blood Institute ( T32HL091812 )",

year = "2015",

month = may,

day = "1",

doi = "10.1016/j.yexcr.2015.03.016",

language = "English",

volume = "333",

pages = "190--194",

number = "2",

}

TY - JOUR

T1 - Lysophospholipid mediators in the vasculature

AU - Mueller, Paul

AU - Ye, Shaojing

AU - Morris, Andrew

AU - Smyth, Susan S.

N1 - Funding Information: This work was supported in part by the National Heart Lung and Blood Institute ( R01HL078663 ); the National Institute of General Medical Sciences ( P20GM103527 ); the National Center for Research Resources ( P20RR021954 ); and the National Center for Advancing Translational Sciences ( UL1TR000117 ) of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This material is the result of work supported in part with resources and the use of facilities at the Lexington VA Medical Center. PM was supported in part by a grant from the National Heart Lung and Blood Institute ( T32HL072743 ) and National Center for Advancing Translational Sciences ( TL1TR000115 ). SY was supported in part by a grant from the National Heart Lung and Blood Institute ( T32HL091812 )

PY - 2015/5/1

Y1 - 2015/5/1

KW - Atherosclerosis

KW - Autotaxin

KW - Endothelial cells

KW - Lipid phosphate phosphatase

KW - Lysophosphatidic acid

KW - Smooth muscle cells

UR - http://www.scopus.com/inward/record.url?scp=84927911084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927911084&partnerID=8YFLogxK

U2 - 10.1016/j.yexcr.2015.03.016

DO - 10.1016/j.yexcr.2015.03.016

M3 - Review article

C2 - 25825155

AN - SCOPUS:84927911084

SN - 0014-4827

VL - 333

SP - 190

EP - 194

JO - Experimental Cell Research

JF - Experimental Cell Research

IS - 2

ER -

Lysophospholipid mediators in the vasculature

Nota bibliográfica

Financiación

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto